抗磷脂酶A受体抗体与特发性膜性肾病全面版课件-2

1、抗磷脂酶A2受体抗体与特发性膜性肾病秦卫松南京军区南京总医院全军肾脏病研究所 全军肾脏病重点实验室抗磷脂酶A2受体抗体与特发性膜性肾病秦卫松研究背景研究方法结论研究背景persistent or relapse of proteinuria despite resection of the tumor.Glassock RJ.Table Anti-PLA2R in Chinese patients with membranous nephropathySDS(Non-reduced)经抗病毒治疗后患者尿蛋白部分缓解或完全缓解；N Engl J Med, ,361: 812 patients:

2、complete remission of the proteinuria after tumor resection;乙肝两对半检测显示大三阳和/或HBV-DNA阳性；Anti-PLA2R in IMN and IMN with complete remissionLow titer of anti-PLA2R existed in 10 of remaining 11 negative IMN.经抗病毒治疗后患者尿蛋白部分缓解或完全缓解；Detection of anti-PLA2R in idiopathic MNN Engl J Med ; 361: 11The remaining 2

3、 patients had persistent proteinuria without tumor resection.Detection of anti-PLA2R in idiopathic MN研究背景persistent or relapse of proteBeck Jr LH, et al. N Engl J Med ; 361: 11Western Blotting of Glomerular Proteins with Serumfrom Patients with IMN.Beck Jr LH, et al. N Engl J Me2 patients: complete

4、remission of the proteinuria after tumor resection;经肾活检病理明确诊断为肾小球膜性病变，免疫荧光以IgG、C3为主, C1q阴性；自身抗体检测阴性，无乙肝、丙肝感染、肿瘤病史，无重金属、有机溶剂接触史；特发性膜性肾病：60例Glassock RJ.经肾活检病理明确诊断为肾小球膜性病变，免疫荧光以IgG、C3为主, C1q阴性；V型狼疮性肾炎：20例Table Anti-PLA2R in Chinese patients with membranous nephropathy经抗病毒治疗后患者尿蛋白部分缓解或完全缓解；Detection of

5、anti-PLA2R in idiopathic MN特发性膜性肾病治疗后缓解的病例：21例Low titer of anti-PLA2R in negative idiopathic MNLaurence H.SDS(Non-reduced)抗磷脂酶A2受体抗体与特发性膜性肾病Glassock RJ. N Engl J Med, ,361: 812 patients: complete remission病例选择特发性膜性肾病：60例肾活检时尿蛋白定量经肾活检病理明确诊断为肾小球膜性病变，光镜观察无内皮或系膜细胞增殖，无内皮下嗜复红物沉积，免疫荧光以IgG、C3为主, C1q阴性；自身抗体检

6、测阴性，无乙肝、丙肝感染、肿瘤病史，无重金属、有机溶剂接触史；特发性膜性肾病治疗后缓解的病例：21例病例选择特发性膜性肾病：60例病例选择V型狼疮性肾炎：20例系统性红斑狼疮、狼疮性肾炎诊断明确；病理上以V型（膜性）病变为主，免疫荧光以颗粒状上皮侧沉积为主，无明显系膜或内皮细胞增殖；肾活检时尿蛋白定量，尿沉渣红细胞100万/ml。乙肝相关膜性肾病：16例经肾活检病理明确诊断为肾小球膜性病变；乙肝两对半检测显示大三阳和/或HBV-DNA阳性；肾组织乙肝抗原染色阳性(其中HBeAg必须阳性)；经抗病毒治疗后患者尿蛋白部分缓解或完全缓解；肾活检时尿蛋白定量。肿瘤相关膜性肾病：10例肾活检时尿蛋白定量

7、病例选择V型狼疮性肾炎：20例从肾小球提取蛋白抗原SDS(Non-reduced)转印至硝酸纤维素膜与患者血清孵育（1：25）一抗，二抗，显色实验方法从肾小球提取蛋白抗原SDS(Non-reduce研究结果研究结果 Detection of anti-PLA2R in idiopathic MN Detection of anti-PLA2R in idRecognition of idiopathic MN serum with deglycosylated PLA2RRecognition of idiopathic MN sThe prevalence of anti-PLA2R in

8、idiopathic MN and secondary MNnAnti-PLA2R%Idiopathic MN604981.7%Lupus MN2015.0%HBV-MN1616.3%Tumor-MN10330%Table Anti-PLA2R in Chinese patients with membranous nephropathyThe prevalence of anti-PLA2R i There was an absence of immunologic disease activity at the time when their serum was sampled, desp

9、ite proteinuria.Why remain 11 IMN patients negative? There was an absence of imLow titer of anti-PLA2R in negative idiopathic MNLow titer of anti-PLA2R existed in 10 of remaining 11 negative IMN.PC: a MN serum that was positive under standard conditions diluted to 1:1000. HC, Healthy control, serum

10、from healthy adult (1:10). Low titer of anti-PLA2R in negAssociation of anti-PLA2R with disease activityAssociation of anti-PLA2R withAnti-PLA2R in IMN and IMN with complete remission81.7%19.0%Anti-PLA2R in IMN and IMN with结 论PLA2R 是中国人特发性膜性肾病的重要靶抗原。抗PLA2R抗体可以作为特发性膜性肾病诊断和疗效判断的特异标志物。结 论PLA2R 是中国人特发性膜

11、性肾病的重要靶抗原。致 谢刘志红院士 David J. Salant Laurence H. Beck, Jr. 陈朝红曾彩虹左科致 谢刘志红院士IgG4 in a glomerulus of a patient with tumor-MN but without circulating anti-PLA2R antibodies. Bright IgG4 in a glomerulus of a patient with tumor-MN and circulating anti-PLA2R antibodies. IgG4 deposition in glomeruli of tumor-MN.IgG4 in a glomerulus of a patiAll three patients with Anti-PLA2R : persistent or relapse of proteinuria despite resection of the tumor. In those patients without anti-PLA2R:2 patients: complete remission of the proteinuria after tumor res